Search

MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer Research

4.5 (499) · $ 15.50 · In stock

MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer Research

MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).

Triple-Negative Breast Cancer - Network of Cancer Research

Triple-Negative Breast Cancer - Network of Cancer Research

Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated

Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated

Embelin is a Nonpeptidic XIAP Inhibitor

Embelin is a Nonpeptidic XIAP Inhibitor

Signal transducer and activator of transcription 3 (STAT3

Signal transducer and activator of transcription 3 (STAT3

Small molecule agents for triple negative breast cancer: Current

Small molecule agents for triple negative breast cancer: Current

Ruxolitinib (INCB018424) is a Selective JAK1/2 Inhibitor for

Ruxolitinib (INCB018424) is a Selective JAK1/2 Inhibitor for

LCH-7749944 is a Potent PAK4 Inhibitor and Induces Apoptosis

LCH-7749944 is a Potent PAK4 Inhibitor and Induces Apoptosis

CYD-4-61 is a Bax Activator Used for Breast Cancer Research

CYD-4-61 is a Bax Activator Used for Breast Cancer Research

Selective inhibitory activity of 9l towards H3K79 methylation in

Selective inhibitory activity of 9l towards H3K79 methylation in

Ilamycin C induces apoptosis and inhibits migration and invasion

Ilamycin C induces apoptosis and inhibits migration and invasion